Showing results (21-30 of 104) with videos related to
Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|January 1, 1997
Disposition of irinotecan and SN-38 following oral and intravenous irinotecan dosing in miceC F Stewart, W C Zamboni, W R Crom, et al.American Journal of Hospital Pharmacy|September 1, 1986
Pharmacist interventions to improve prescribing of vancomycin and tobramycinC V Fletcher, R M Giese, J H RodmanPharmacotherapy|July 1, 1996
Formation of platinum-DNA adducts in pediatric patients receiving carboplatinM E Tonda, D J Murry, J H RodmanThe Journal of Pediatrics|May 1, 1987
Methotrexate bioavailability after oral and intramuscular administration in childrenM E Teresi, W R Crom, K E Choi, et al.Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1993
Saturable elimination and saturable protein binding account for flavone acetic acid pharmacokineticsM V Relling, R R Evans, S Groom, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Liver volume as a determinant of drug clearance in children and adolescentsD J Murry, W R Crom, W E Reddick, et al.Clinical Pharmacology and Therapeutics|June 1, 1992
The pharmacokinetics of high-dose carboplatin in pediatric patients with cancerT Madden, M Sunderland, V M Santana, et al.Medical and Pediatric Oncology|January 1, 1994
Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosisS Gururangan, M Horner, J H Rodman, et al.The Journal of Infectious Diseases|September 1, 1996
A systemic and cellular model for zidovudine plasma concentrations and intracellular phosphorylation in patientsJ H Rodman, B Robbins, P M Flynn, et al.Clinical Pharmacology and Therapeutics|May 1, 1996
Hepatic drug clearance in patients with mild cystic fibrosisG L Kearns, W R Crom, K H Karlson, et al.Pageof 11